Freedom Ιωαννα Βλαχογιαννη - Av Gel Freedom Active - 02.04.2012-1

8/18/2019 Freedom Ιωαννα Βλαχογιαννη - Av Gel Freedom Active - 02.04.2012-1

1/21

!"# $%#&'( – Aloe VeraDrinking Gel Active Freedom

!"#$$% &. '(%)*+,#$$-, MSc

.,%,/*(0+*1 –.,%/2*3*(0+*1

45*673,% .,8#9/"2 &%2*9*5:;*


2/21

Aloe Vera Drinking Gel Active Freedom

)*+,-,./0: 1234 Aloe Vera Barbadensis Miller (5$6/738./',88%), *9%'4*µ- /#44-:'(#*, +*µ;*/(


3/21


I.-,%#F./0 +,#.>3B-

6(0 90 ml %)5I

J3%µB93= 35 kcal -

$%


4/21


!"# +*+,-,./':1# MSM -(,./-,-+,0@C/3 -;' ,# *9%'4*µ- /#44-:'(#*

A(,./%#*'µ3(- -;#,34"+µ-,-: @3,./A 3;B9%-+C +3 +*(9*-+µ' µ3 :4*/#2-µB(C, 3(M +3 0443= µ34",3= 93 F-B(3,-. (- ">3.

/0;#.- 3;B9%-+C

(Brien S, et al. Evid Based Complement Alternat Med. 2009 May 27.Usha PR, et al. Clin Drug Investig. 2004;24(6):353-63.)


5/21

N#44-:'(#

• I#µ./A ;%


6/21

N#44-:'(#

• I.0F#%#. ,?;#. ;#* 9.-F"%#*( +,C 9#µA /-. +,C( -44C4#*>B- ,3. C O.,-µB(C C

•1%.;4A "4./-

•E8"%>3,-. -;' ,# /?,,-%# ( ICµ';#*4#= N


7/21

K9%'4*µ- N#44-:'(#*

• P443= #(#µ-+B3=: *9%#4*µ"(# /#44-:'(#, 234-,B(C, ;3;,B9.- /#44-:'(#* /-. 044-

•N-4A -;#%%'FC+C

•1# /#44-:'(# -;#µ#(M(3,-. /*%B


8/21

•D.#9.-@3+.µ',C,-:$3.%0µ-,- +3 ;#(,B/.- µ3 3;3+Cµ-+µ"(# *9%'4*µ- /#44-:'(#*, -;#%%#F0,-. +,# "(,3%# ;0(


9/21

K9%'4*µ- N#44-:'(#*

•N4.(./"= µ34",3= +3 -+@3(3B= µ3 #+,3#-%@%B,.9- (R6)

),.= ;3%.++',3%3= 7-10 g *9%#4*µ"(#* /#44-:'(#*, /0@3 µ"%- :.- 3 µA(3=, O34,B


10/21

K9%'4*µ- N#44-:'(#*

•5 -;#%%'FC+C ,#* *9%#4*µ"(#* /#44-:'(#* +*(9"3,-. µ3 +,-,.+,./0 +Cµ-(,./A -?8C+C ,C= +?(@3+C= µ-/%#µ#%B


11/21

K9%'4*µ- N#44-:'(#*

•5 /-,-(04


12/21

S4*/#2-µB(C

•5 :4*/#2-µB(C 3B(-. "(-= *9-,#9.-4*,'= µ#(#+-/>-%B,C= +*(9393µ"(#= µ3 "(- -µ.(#8? (Jerosch J. Int J Rheumatol. 2011;2011:969012.)

•)*(,B@3,-. -;' ,C :4*/'2C +3 +>39'( /0@3 -(@%M;.(# .+,' /-. O%B+/3,-. /*%B'(9%#*=

• 5 @3../A :4*/#2-µB(C ;#* 3B(-. /-. C +*(A@C= µ#%FA ;#* -;-(,0,-. +,- 9.0F#%- +*µ;4C%Mµ-,- 9.-,%#FA=

•In vitro

5 :4*/#2-µB(C 3(.+>?3. ,C( ;-%-:


13/21

S4*/#2-µB(C

6;' /4.(./"= µ34",3= F-B(3,-. ',. C µ-/%#>%'(.- @3%-;3B- µ3 :4*/#2-µB(C

6) 73.M(3. ,#( ;'(# D) D34,.M(3. ,C 43.,#*%:B- /-. ,C( /.(C,./',C,- ,C= 0%@%


14/21

G#(9%#.,B(C

•

5 >#(9%#.,B(C 3B(-. "(- ;#4*µ3%"= 9.+-/>-%B,C, ,C= :4*/#2-µ.(#:4*/0(C=

•5 @3../A >#(9%#.,B(C (CS) 3B(-. +Cµ-(,./' +*+,-,./' ,C= 38


15/21

G#(9%#.,B(C

In vitro

•5 CS -(-+,"443. ,.= 9.-9./-+B3= ;#* #9C:#?( +,C( /-,-+,%#FA ,#* >'(9%#*

• I.3:3B%3. -(-O#4./"= 9.-9./-+B3= ;#* 3µ;4"/#(,-. +,C 9.-µ'%F'(9%#*

•)3 /-44."%:3.3= >#(9%#/*,,0%


16/21

D.,-µB(C E

5 O.,-µB(C E 43.,#*%:3B


17/21

D.,-µB(C C

• K9-,#9.-4*,A O.,-µB(C

• 6(,.#83.9


18/21

D.,-µB(C C

• 5 >#%A:C+C O.,-µB(C= C F-B(3,-. (- 9%- ;%#4C;,./0 +,C( #+,3#-%@%B,.9- (Peregoy J et al. Public Health Nutr. 2011 Apr;14(4):709-15. )

• 5 #+,3#-%@%B,.9- -%-/,C%B23,-. -;'

µ3.


19/21

•

5 ,234 ,C= -4'C= ">3. -(,.F43:µ#(M9C 9%0+C •7;#%3B (- 9%0+3. ;%#4C;,./0 +,- ;%#O4Aµ-,- ;#* 9Cµ.#*%:3B C F-%µ-/3*,./A -:-%B,3= ,C= ;%#


20/21


1. ,# 83>


21/21

EKG6UV)1W $RLK!!!!

Freedom Ιωαννα Βλαχογιαννη - Av Gel Freedom Active - 02.04.2012-1

Documents

Transcript of Freedom Ιωαννα Βλαχογιαννη - Av Gel Freedom Active - 02.04.2012-1